Carmen Sucharov
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 24 | 2025 | 701 | 5.550 |
Why?
| | Cardiomyopathy, Dilated | 19 | 2025 | 359 | 4.760 |
Why?
| | Myocytes, Cardiac | 19 | 2025 | 556 | 3.710 |
Why?
| | Myocardium | 12 | 2020 | 939 | 2.090 |
Why?
| | Heart Failure | 16 | 2023 | 2323 | 1.740 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 26 | 1.450 |
Why?
| | Gene Expression Regulation | 14 | 2018 | 2608 | 1.350 |
Why?
| | Connexin 43 | 3 | 2025 | 36 | 1.310 |
Why?
| | Ventricular Remodeling | 4 | 2021 | 276 | 1.170 |
Why?
| | Receptors, Adrenergic, beta | 4 | 2016 | 61 | 1.150 |
Why?
| | Phosphodiesterase 3 Inhibitors | 3 | 2019 | 14 | 1.140 |
Why?
| | Heart Ventricles | 13 | 2021 | 760 | 1.130 |
Why?
| | YY1 Transcription Factor | 6 | 2015 | 25 | 1.090 |
Why?
| | Phosphoric Diester Hydrolases | 3 | 2016 | 53 | 0.930 |
Why?
| | Histone Deacetylases | 5 | 2013 | 210 | 0.860 |
Why?
| | Cardiomegaly | 6 | 2025 | 174 | 0.830 |
Why?
| | Phosphorylation | 9 | 2021 | 1732 | 0.820 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2017 | 120 | 0.810 |
Why?
| | Serum | 3 | 2019 | 58 | 0.800 |
Why?
| | Calcium-Binding Proteins | 4 | 2021 | 219 | 0.790 |
Why?
| | RNA-Binding Proteins | 2 | 2025 | 462 | 0.780 |
Why?
| | Rats | 18 | 2025 | 5597 | 0.750 |
Why?
| | Transcriptome | 5 | 2021 | 1045 | 0.740 |
Why?
| | RNA, Messenger | 11 | 2024 | 2832 | 0.740 |
Why?
| | Amniotic Fluid | 2 | 2024 | 79 | 0.710 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 145 | 0.700 |
Why?
| | Focal Adhesions | 1 | 2021 | 47 | 0.690 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 26 | 0.670 |
Why?
| | Biomarkers | 8 | 2024 | 4271 | 0.640 |
Why?
| | Extracellular Matrix | 2 | 2021 | 553 | 0.620 |
Why?
| | Down-Regulation | 7 | 2025 | 627 | 0.620 |
Why?
| | Heart Defects, Congenital | 4 | 2021 | 914 | 0.600 |
Why?
| | Receptors, Adrenergic, beta-1 | 2 | 2011 | 24 | 0.590 |
Why?
| | Adenylyl Cyclases | 2 | 2016 | 60 | 0.590 |
Why?
| | Phosphodiesterase Inhibitors | 2 | 2016 | 73 | 0.570 |
Why?
| | Animals, Newborn | 9 | 2025 | 902 | 0.570 |
Why?
| | Signal Transduction | 11 | 2023 | 5226 | 0.560 |
Why?
| | Heart | 5 | 2025 | 636 | 0.550 |
Why?
| | Animals | 39 | 2026 | 38058 | 0.550 |
Why?
| | Calcium | 2 | 2021 | 1183 | 0.540 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 177 | 0.530 |
Why?
| | Protein Kinase C | 2 | 2011 | 252 | 0.530 |
Why?
| | Cardiomyopathies | 1 | 2021 | 338 | 0.520 |
Why?
| | Ventricular Myosins | 4 | 2025 | 39 | 0.520 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2017 | 250 | 0.520 |
Why?
| | Child | 24 | 2025 | 22633 | 0.510 |
Why?
| | Ventricular Function, Left | 3 | 2018 | 541 | 0.500 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2025 | 905 | 0.480 |
Why?
| | Specimen Handling | 1 | 2018 | 186 | 0.470 |
Why?
| | Plasma | 1 | 2018 | 225 | 0.470 |
Why?
| | Cells, Cultured | 15 | 2025 | 4154 | 0.470 |
Why?
| | Bleomycin | 5 | 2020 | 253 | 0.470 |
Why?
| | Exosomes | 1 | 2017 | 104 | 0.460 |
Why?
| | Child, Preschool | 17 | 2025 | 11787 | 0.460 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 341 | 0.450 |
Why?
| | Transcription Factors | 7 | 2016 | 1741 | 0.440 |
Why?
| | Cyclic AMP | 5 | 2019 | 209 | 0.440 |
Why?
| | Humans | 57 | 2025 | 144759 | 0.440 |
Why?
| | Myosin Heavy Chains | 5 | 2025 | 185 | 0.430 |
Why?
| | Polymorphism, Genetic | 2 | 2019 | 612 | 0.400 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 9 | 0.400 |
Why?
| | Gene Expression | 7 | 2017 | 1490 | 0.400 |
Why?
| | Case-Control Studies | 8 | 2025 | 3604 | 0.400 |
Why?
| | Caloric Restriction | 2 | 2026 | 127 | 0.400 |
Why?
| | Female | 40 | 2026 | 78271 | 0.390 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 301 | 0.390 |
Why?
| | Fetal Blood | 2 | 2025 | 342 | 0.380 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2012 | 168 | 0.380 |
Why?
| | Heart Transplantation | 4 | 2016 | 736 | 0.380 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 35 | 0.370 |
Why?
| | Male | 36 | 2025 | 72315 | 0.350 |
Why?
| | Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 3 | 0.340 |
Why?
| | DNA-Binding Proteins | 5 | 2005 | 1499 | 0.340 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2011 | 45 | 0.340 |
Why?
| | Mitochondria, Heart | 3 | 2024 | 102 | 0.340 |
Why?
| | Sex Characteristics | 3 | 2019 | 790 | 0.330 |
Why?
| | Fetal Growth Retardation | 3 | 2026 | 587 | 0.330 |
Why?
| | Recovery of Function | 1 | 2015 | 707 | 0.320 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 125 | 0.320 |
Why?
| | Heart Diseases | 1 | 2013 | 349 | 0.310 |
Why?
| | RNA | 1 | 2016 | 940 | 0.300 |
Why?
| | Isoproterenol | 3 | 2018 | 97 | 0.290 |
Why?
| | Gene Expression Profiling | 6 | 2021 | 1782 | 0.290 |
Why?
| | Milrinone | 2 | 2021 | 26 | 0.280 |
Why?
| | Myocardial Infarction | 2 | 2018 | 1209 | 0.280 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2021 | 33 | 0.280 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 570 | 0.270 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 54 | 0.270 |
Why?
| | Cell Line | 3 | 2025 | 2882 | 0.270 |
Why?
| | 3' Untranslated Regions | 3 | 2025 | 152 | 0.270 |
Why?
| | Myocardial Contraction | 3 | 2019 | 298 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 4 | 2025 | 2527 | 0.260 |
Why?
| | Cardiolipins | 2 | 2020 | 82 | 0.250 |
Why?
| | Trophoblasts | 2 | 2026 | 216 | 0.240 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 65 | 0.240 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 285 | 0.240 |
Why?
| | Mice | 14 | 2026 | 18339 | 0.230 |
Why?
| | Disease Models, Animal | 8 | 2026 | 4557 | 0.230 |
Why?
| | Lung Injury | 2 | 2018 | 237 | 0.230 |
Why?
| | Pericardium | 1 | 2025 | 62 | 0.220 |
Why?
| | Organogenesis | 1 | 2025 | 65 | 0.220 |
Why?
| | Antigens, Nuclear | 1 | 2004 | 16 | 0.220 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5992 | 0.210 |
Why?
| | Infant | 9 | 2020 | 10034 | 0.210 |
Why?
| | Inflammation | 4 | 2020 | 2878 | 0.210 |
Why?
| | Neovascularization, Physiologic | 1 | 2026 | 194 | 0.210 |
Why?
| | Protein Kinases | 1 | 2006 | 315 | 0.210 |
Why?
| | Echocardiography | 2 | 2021 | 652 | 0.210 |
Why?
| | Natriuretic Peptide, Brain | 3 | 2025 | 111 | 0.200 |
Why?
| | Fetal Heart | 1 | 2024 | 57 | 0.200 |
Why?
| | Protein Isoforms | 1 | 2025 | 402 | 0.200 |
Why?
| | Age Factors | 6 | 2018 | 3333 | 0.190 |
Why?
| | Sarcomeres | 1 | 2023 | 98 | 0.190 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2014 | 196 | 0.190 |
Why?
| | Glutathione | 1 | 2024 | 375 | 0.180 |
Why?
| | Adolescent | 8 | 2025 | 22428 | 0.180 |
Why?
| | Pregnancy | 6 | 2026 | 7190 | 0.180 |
Why?
| | Endopeptidase K | 1 | 2021 | 18 | 0.180 |
Why?
| | Receptor, EphA2 | 2 | 2018 | 17 | 0.180 |
Why?
| | Adult | 12 | 2025 | 40449 | 0.180 |
Why?
| | Ribonucleases | 1 | 2021 | 49 | 0.170 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2024 | 219 | 0.170 |
Why?
| | Light Coagulation | 1 | 2021 | 10 | 0.170 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2013 | 758 | 0.170 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.170 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2182 | 0.170 |
Why?
| | Fetoscopy | 1 | 2021 | 33 | 0.170 |
Why?
| | Phenotype | 5 | 2023 | 3162 | 0.170 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 134 | 0.170 |
Why?
| | Mutation | 4 | 2023 | 4089 | 0.170 |
Why?
| | Up-Regulation | 3 | 2025 | 851 | 0.160 |
Why?
| | Cell Differentiation | 2 | 2025 | 2050 | 0.160 |
Why?
| | Drainage | 1 | 2021 | 185 | 0.160 |
Why?
| | Biological Products | 1 | 2023 | 252 | 0.160 |
Why?
| | Cluster Analysis | 1 | 2021 | 521 | 0.150 |
Why?
| | Prospective Studies | 6 | 2024 | 7990 | 0.150 |
Why?
| | Extracellular Fluid | 1 | 2019 | 36 | 0.150 |
Why?
| | Apoptosis | 2 | 2019 | 2430 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 91 | 0.150 |
Why?
| | Atrial Natriuretic Factor | 3 | 2025 | 57 | 0.150 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 8 | 0.150 |
Why?
| | Chromosome Fragility | 1 | 1999 | 2 | 0.150 |
Why?
| | Troponin I | 1 | 2019 | 72 | 0.150 |
Why?
| | Ephrin-A2 | 1 | 2018 | 4 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 294 | 0.150 |
Why?
| | Trinucleotide Repeats | 1 | 1999 | 31 | 0.140 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 121 | 0.140 |
Why?
| | Fever | 1 | 2020 | 311 | 0.140 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 23 | 0.140 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.140 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 62 | 0.140 |
Why?
| | HEK293 Cells | 1 | 2021 | 744 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 459 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2168 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2145 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2019 | 143 | 0.140 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 108 | 0.140 |
Why?
| | Prognosis | 3 | 2018 | 4282 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 592 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 983 | 0.130 |
Why?
| | Freezing | 1 | 2018 | 86 | 0.130 |
Why?
| | Blotting, Western | 3 | 2016 | 1187 | 0.130 |
Why?
| | Myocarditis | 1 | 2018 | 102 | 0.130 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.130 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2016 | 9 | 0.130 |
Why?
| | Cell Size | 1 | 2017 | 92 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2020 | 303 | 0.120 |
Why?
| | Kidney | 2 | 2024 | 1495 | 0.120 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 103 | 0.120 |
Why?
| | Pilot Projects | 1 | 2022 | 1886 | 0.120 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 95 | 0.120 |
Why?
| | Renin-Angiotensin System | 1 | 2017 | 78 | 0.120 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 368 | 0.120 |
Why?
| | Death, Sudden, Cardiac | 1 | 2018 | 230 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 865 | 0.120 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 3 | 2005 | 17 | 0.120 |
Why?
| | Vascular Resistance | 1 | 2017 | 367 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 297 | 0.120 |
Why?
| | Transcription, Genetic | 5 | 2013 | 1496 | 0.120 |
Why?
| | Receptors, Nicotinic | 1 | 2018 | 321 | 0.120 |
Why?
| | Protein Binding | 4 | 2013 | 2273 | 0.120 |
Why?
| | Critical Illness | 1 | 2022 | 891 | 0.120 |
Why?
| | Sympathetic Nervous System | 1 | 2017 | 178 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 187 | 0.120 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 191 | 0.110 |
Why?
| | Collagen Type III | 1 | 2015 | 18 | 0.110 |
Why?
| | Liver | 1 | 2024 | 1887 | 0.110 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 361 | 0.110 |
Why?
| | DNA Primers | 3 | 2011 | 512 | 0.110 |
Why?
| | Transcriptional Activation | 2 | 2008 | 383 | 0.110 |
Why?
| | Middle Aged | 10 | 2018 | 35875 | 0.110 |
Why?
| | Electron Transport Complex IV | 1 | 1995 | 62 | 0.110 |
Why?
| | Hot Temperature | 1 | 2018 | 407 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 156 | 0.110 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1995 | 117 | 0.110 |
Why?
| | Lung | 4 | 2024 | 4109 | 0.110 |
Why?
| | Microfilament Proteins | 1 | 2015 | 135 | 0.110 |
Why?
| | Antibiotics, Antineoplastic | 3 | 2020 | 139 | 0.100 |
Why?
| | Heart Rate | 1 | 2018 | 855 | 0.100 |
Why?
| | Cohort Studies | 3 | 2022 | 5960 | 0.100 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 1980 | 0.100 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 276 | 0.100 |
Why?
| | Stroke Volume | 1 | 2017 | 651 | 0.100 |
Why?
| | Biopsy | 1 | 2017 | 1075 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2016 | 1306 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2925 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 614 | 0.090 |
Why?
| | Peptides | 1 | 2018 | 995 | 0.090 |
Why?
| | Promoter Regions, Genetic | 3 | 2004 | 1257 | 0.090 |
Why?
| | Nanoparticles | 1 | 2018 | 519 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 851 | 0.090 |
Why?
| | Obesity | 1 | 2025 | 3077 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2018 | 965 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 1995 | 623 | 0.090 |
Why?
| | Young Adult | 2 | 2021 | 14105 | 0.080 |
Why?
| | Fibrosis | 3 | 2019 | 548 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2016 | 748 | 0.080 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2014 | 248 | 0.080 |
Why?
| | Organ Specificity | 1 | 2011 | 312 | 0.080 |
Why?
| | Heart-Assist Devices | 1 | 2016 | 567 | 0.080 |
Why?
| | Glycine | 1 | 2011 | 187 | 0.080 |
Why?
| | Arginine | 1 | 2011 | 262 | 0.080 |
Why?
| | Genotype | 2 | 2020 | 1833 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2011 | 766 | 0.080 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 318 | 0.070 |
Why?
| | Cell Movement | 1 | 2013 | 965 | 0.070 |
Why?
| | PPAR alpha | 1 | 2008 | 54 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 269 | 0.070 |
Why?
| | Heart Function Tests | 1 | 2008 | 59 | 0.070 |
Why?
| | Placenta | 2 | 2026 | 780 | 0.070 |
Why?
| | Adenosine Monophosphate | 2 | 2021 | 86 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2008 | 138 | 0.070 |
Why?
| | Fibroblasts | 1 | 2013 | 1034 | 0.070 |
Why?
| | Time Factors | 4 | 2018 | 7173 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 24 | 0.060 |
Why?
| | Genetic Markers | 2 | 2018 | 331 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2006 | 5 | 0.060 |
Why?
| | Indole Alkaloids | 1 | 2006 | 7 | 0.060 |
Why?
| | Computational Biology | 1 | 2011 | 680 | 0.060 |
Why?
| | Carbazoles | 1 | 2006 | 56 | 0.060 |
Why?
| | Protein Phosphatase 2 | 1 | 2006 | 41 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2019 | 509 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2013 | 2496 | 0.060 |
Why?
| | Placentation | 1 | 2026 | 53 | 0.060 |
Why?
| | Adrenergic beta-Agonists | 1 | 2006 | 92 | 0.060 |
Why?
| | Cardiac Myosins | 1 | 2025 | 37 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 72 | 0.060 |
Why?
| | Cytoplasm | 1 | 2006 | 269 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 457 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 81 | 0.060 |
Why?
| | Acute Coronary Syndrome | 1 | 2008 | 293 | 0.050 |
Why?
| | Ku Autoantigen | 1 | 2004 | 12 | 0.050 |
Why?
| | Calcium Channels, L-Type | 1 | 2006 | 118 | 0.050 |
Why?
| | Protein Transport | 1 | 2006 | 441 | 0.050 |
Why?
| | Animals, Genetically Modified | 1 | 2025 | 250 | 0.050 |
Why?
| | Mesoderm | 1 | 2025 | 150 | 0.050 |
Why?
| | Aged | 6 | 2018 | 25913 | 0.050 |
Why?
| | Epithelium | 1 | 2025 | 314 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 115 | 0.050 |
Why?
| | Citrate (si)-Synthase | 1 | 2024 | 57 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 107 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 862 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 20 | 0.050 |
Why?
| | Actins | 1 | 2006 | 425 | 0.050 |
Why?
| | Suppression, Genetic | 1 | 2003 | 26 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2025 | 210 | 0.050 |
Why?
| | Infant, Newborn | 3 | 2024 | 6429 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 210 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 195 | 0.050 |
Why?
| | Haplotypes | 2 | 2018 | 490 | 0.050 |
Why?
| | Zebrafish Proteins | 1 | 2025 | 311 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 339 | 0.050 |
Why?
| | Mutagenesis | 1 | 2003 | 192 | 0.050 |
Why?
| | Gene Deletion | 1 | 2003 | 389 | 0.040 |
Why?
| | Sheep | 1 | 2024 | 880 | 0.040 |
Why?
| | Zebrafish | 1 | 2025 | 528 | 0.040 |
Why?
| | Ischemia | 1 | 2024 | 421 | 0.040 |
Why?
| | Linear Models | 2 | 2016 | 854 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3409 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 384 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2024 | 527 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 126 | 0.040 |
Why?
| | Transfection | 2 | 2007 | 940 | 0.040 |
Why?
| | Minisatellite Repeats | 1 | 1999 | 36 | 0.040 |
Why?
| | Disease Progression | 1 | 2007 | 2847 | 0.040 |
Why?
| | X Chromosome | 1 | 1999 | 67 | 0.040 |
Why?
| | Flecainide | 1 | 2018 | 8 | 0.040 |
Why?
| | Brazil | 1 | 1999 | 180 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 35 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 211 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 727 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 85 | 0.030 |
Why?
| | Guinea Pigs | 1 | 2018 | 159 | 0.030 |
Why?
| | Protective Factors | 1 | 2018 | 99 | 0.030 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 72 | 0.030 |
Why?
| | Fragile X Syndrome | 1 | 1999 | 118 | 0.030 |
Why?
| | DNA | 1 | 2004 | 1463 | 0.030 |
Why?
| | Genetics, Population | 1 | 1999 | 214 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 310 | 0.030 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2018 | 142 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2024 | 1339 | 0.030 |
Why?
| | Inflammasomes | 1 | 2018 | 146 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 19 | 0.030 |
Why?
| | Sampling Studies | 1 | 2016 | 99 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 21 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2018 | 372 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 596 | 0.030 |
Why?
| | Transcription Initiation Site | 1 | 2016 | 43 | 0.030 |
Why?
| | Transcription Elongation, Genetic | 1 | 2016 | 24 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 395 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 365 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 284 | 0.030 |
Why?
| | Acetylation | 1 | 2016 | 252 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2019 | 737 | 0.030 |
Why?
| | GA-Binding Protein Transcription Factor | 1 | 1995 | 5 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 797 | 0.030 |
Why?
| | Action Potentials | 1 | 2018 | 506 | 0.030 |
Why?
| | 3T3 Cells | 1 | 1995 | 156 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1995 | 56 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1995 | 162 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2190 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1087 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1995 | 276 | 0.030 |
Why?
| | Exons | 1 | 1995 | 358 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1995 | 381 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 17 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 510 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 66 | 0.030 |
Why?
| | Plasmids | 1 | 1995 | 379 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1995 | 2930 | 0.020 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 64 | 0.020 |
Why?
| | Tissue Donors | 1 | 2016 | 424 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 115 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 112 | 0.020 |
Why?
| | HeLa Cells | 1 | 1995 | 650 | 0.020 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 197 | 0.020 |
Why?
| | RNA Polymerase II | 1 | 2016 | 351 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2016 | 961 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 202 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2013 | 451 | 0.020 |
Why?
| | Hydrogels | 1 | 2019 | 700 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 628 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 561 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 262 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1985 | 0.020 |
Why?
| | Binding Sites | 1 | 1995 | 1329 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 3121 | 0.020 |
Why?
| | Exercise | 1 | 2003 | 2201 | 0.020 |
Why?
| | Cattle | 1 | 2013 | 1000 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1511 | 0.020 |
Why?
| | MADS Domain Proteins | 1 | 2009 | 4 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2009 | 45 | 0.020 |
Why?
| | MEF2 Transcription Factors | 1 | 2009 | 51 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2363 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2008 | 45 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2008 | 40 | 0.020 |
Why?
| | Registries | 2 | 2008 | 2385 | 0.020 |
Why?
| | Genes | 1 | 2008 | 226 | 0.020 |
Why?
| | Homozygote | 1 | 2008 | 199 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2008 | 273 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 173 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 315 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1134 | 0.020 |
Why?
| | Gene Frequency | 1 | 2008 | 481 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 32 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 398 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 101 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3671 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 618 | 0.010 |
Why?
| | United States | 2 | 2018 | 15966 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 416 | 0.010 |
Why?
| | Genetic Testing | 1 | 2007 | 478 | 0.010 |
Why?
| | Risk Factors | 1 | 2018 | 10779 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 570 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 984 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1370 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2834 | 0.010 |
Why?
| | Hospitalization | 1 | 2008 | 2433 | 0.010 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 10 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1995 | 80 | 0.010 |
Why?
| | TATA Box | 1 | 1995 | 22 | 0.010 |
Why?
| | Deoxyribonuclease I | 1 | 1995 | 41 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 204 | 0.010 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1995 | 96 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1995 | 275 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1995 | 919 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 11679 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1995 | 370 | 0.010 |
Why?
|
|
Sucharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|